Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE)
Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer(2024)
Key words
Iruplinalkib,Anaplastic lymphoma kinase,Tyro-sine kinase inhibitor,Non-small cell lung cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined